Ruxolitinib Impurity 246
- CAS191605-10-4
- CatalogueRS-R005020
- FormulaC20H18O10
- MW418.35
BACK ORDER
On this page
Product identification
| Product name | Ruxolitinib Impurity 246 |
|---|---|
| Catalogue No. | RS-R005020 |
| CAS No. | 191605-10-4 |
| Molecular formula | C20H18O10 |
| Molecular weight | 418.35 |
| Availability | Back order— restocking can be arranged, about 1–2 weeks |
| Standard type | Impurity Reference Standards |
| Drug substance | Ruxolitinib |
| Also known as | Ruxolitinib Impurity 27 |
| Storage | Refer to the certificate of analysis (COA) supplied with each lot |
| Intended use | For laboratory and research use only. Not for human or veterinary use. |
What is stated on the certificate
Content and purity are assigned per lot and stated on the certificate of analysis issued for the batch you receive — they are not a catalogue-level figure. The certificate records the tests performed, the specification applied and the result obtained for that lot.
| Field | Basis |
|---|---|
| Identity | Spectroscopic and chromatographic methods appropriate to the material |
| Purity | Chromatographic purity, area normalisation unless stated otherwise |
| Assay / content | Mass balance, corrected for the stated volatiles and residue |
| Catalogue and batch numbers | RS-R005020 / batch number on the certificate |
| Retest date | Printed on the certificate for the lot supplied |
Frequently asked
What documentation is supplied with this lot?
A certificate of analysis (COA) is issued for the lot you receive. It records the catalogue number
RS-R005020 and the batch number, the tests performed, the
specification applied and the result obtained. A safety data sheet is supplied with the shipment.
Is the assigned value given on an “as is” basis?
Content and purity are stated per lot on the certificate of analysis, on an “as is” basis unless the certificate says otherwise. The analytical basis for the assigned value is stated on the certificate.
How should this material be stored?
Store as stated: Refer to the certificate of analysis (COA) supplied with each lot. Re-test before use beyond the retest date printed on the certificate.
Do you supply pack sizes other than those listed?
Pack sizes are confirmed with the quotation. Quantities beyond the standard pack sizes can be quoted — send the quantity you need with your enquiry.
Finding this standard
Buyers reach this compound by CAS number, by catalogue number, through the drug substance it belongs to, or through the type of standard it is. Those routes all start here:
- Other impurities of Ruxolitinib
- Impurity Reference Standards of this kind
- Documents for this item (COA, SDS)
- Certificate of analysis for RS-R005020
- Request a quotation for RS-R005020
Searching another way? Send the structure, a SMILES string or the pharmacopoeial name — a CAS number is not required for a non-compendial impurity. Write to sales@rssechem.com.
Other standards of Ruxolitinib
All 78 further standards are listed here — every link is in the page, not loaded later.
-
(R)-Ruxolitinib
IN STOCKRS-U093216 -
(S)-Ruxolitinib
IN STOCKRS-R005012 -
(S)-Ruxolitinib Phosphate
IN STOCKRS-R005011 -
Ruxolitinib Hydrochloride
IN STOCKRS-R005032 -
(4-Chloro-7H-pyrrolo[2,3-d]pyrimidin-7-yl)methyl Pivalate
IN STOCKRS-R005013 -
(5S)-5-Cyclopentyl-3-pyrazolidinone
IN STOCKRS-I011396 -
(betaR)-beta-Cyclopentyl-4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazole-1-propanenitrile sulfate
CUSTOM SYNTHESISRS-U043241 -
(E)-3-Cyclopentylacrylic acid
CUSTOM SYNTHESISRS-I006013 -
(E)-ethyl 3-cyclopentylacrylate(WXC02698)
CUSTOM SYNTHESISRS-U047447 -
(S)-3-(4-Bromo-1H-pyrazol-1-yl)-3-cyclopentylpropanamide
CUSTOM SYNTHESISRS-Z401H11 -
(Z)-3-hydroxy-2-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)acrylaldehyde
IN STOCKRS-R005042 -
3-(1-methylcyclobutyl)acrylonitrile
IN STOCKRS-R005021 -
3-(4-Bromo-1H-pyrazol-1-yl)-3-cyclopentylpropanoic Acid
IN STOCKRS-P003983 -
3-Cyclopentyl-3-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl)propanenitrile
CUSTOM SYNTHESISRS-P001868 -
3-Cyclopentylacrylohydrazide
IN STOCKRS-I002315 -
3-keto cyclopentyl Ruxolitinib
IN STOCKRS-R005030 -
4,4-Dimethoxybutanenitrile
IN STOCKRS-U004284 -
4-Amino-6-methylpyrimidine-5-carboxylic acid
BACK ORDERRS-U074925 -
4-Methyl-7H-pyrrolo[2,3-d]pyrimidine
IN STOCKRS-P011A0U -
5-Cyclopentyl-1,2-dihydro-3H-pyrazol-3-one
IN STOCKRS-D110122 -
5-Cyclopentyl-1H-pyrazol-3-amine
IN STOCKRS-U090599 -
7H-Pyrrolo[2,3-d]pyrimidin-4-ol
IN STOCKRS-R005268 -
Benzyl 4-methyl-7H-pyrrolo[2,3-d]pyrimidine-7-carboxylate
IN STOCKRS-Z401HK5 -
CTP-543
CUSTOM SYNTHESISRS-U045118 -
Cyclopentyl Hydrazine
IN STOCKRS-U045198 -
Ethyl (2E)-3-cyclopentylprop-2-enoate
IN STOCKRS-Z406Y4K -
Methyl (E)-3-cyclopentylacrylate
CUSTOM SYNTHESISRS-R005006 -
Methyl 3-(4-bromo-1H-pyrazol-1-yl)-3-cyclopentylpropanoate
CUSTOM SYNTHESISRS-Z401FCH -
Rac-Ruxolitinib 6-hydroxy-5-oxo-Impurity
CUSTOM SYNTHESISRS-R005027 -
rac-Ruxolitinib-d8
IN STOCKRS-R005029 -
Ruxolitinib Amide Impurity
IN STOCKRS-R005008 -
Ruxolitinib D9
CUSTOM SYNTHESISRS-R005034 -
Ruxolitinib Hemifumarate Reference Standard
BACK ORDERRS-U093132 -
Ruxolitinib M18 Metabolite
IN STOCKRS-R005016 -
Ruxolitinib M49 Metabolite
CUSTOM SYNTHESISRS-R005037 -
Ruxolitinib mesilate
BACK ORDERRS-Z412PQ1 -
Ruxolitinib S-isomer Oxalate
IN STOCKRS-R005031 -
Ruxolitinib-amide
IN STOCKRS-R005019 -
Ruxolitinib Impurity 3
IN STOCKRS-R005015 -
Ruxolitinib Impurity 5
IN STOCKRS-R005022 -
Ruxolitinib Impurity 13
BACK ORDERRS-R005026 -
Ruxolitinib Impurity 18
CUSTOM SYNTHESISRS-I001ASO -
Ruxolitinib Impurity 28
CUSTOM SYNTHESISRS-I001A32 -
Ruxolitinib Impurity 40
IN STOCKRS-I001AQT -
Ruxolitinib Impurity 42
CUSTOM SYNTHESISRS-R005024 -
Ruxolitinib Impurity 43
IN STOCKRS-R005001 -
Ruxolitinib Impurity 46
IN STOCKRS-Z395V3F -
Ruxolitinib Impurity 47
IN STOCKRS-I001920 -
Ruxolitinib Impurity 48
IN STOCKRS-R005003 -
Ruxolitinib Impurity 58
IN STOCKRS-R005010 -
Ruxolitinib Impurity 89
BACK ORDERRS-I001ANJ -
Ruxolitinib Impurity 96
IN STOCKRS-I001B3L -
Ruxolitinib Impurity 111 L-Tartrate
BACK ORDERRS-Z401F90 -
Ruxolitinib Impurity 121
IN STOCKRS-I001BW1 -
Ruxolitinib Impurity 132
CUSTOM SYNTHESISRS-U211O8B -
Ruxolitinib Impurity 134
IN STOCKRS-I001BGI -
Ruxolitinib Impurity 151
CUSTOM SYNTHESISRS-U211O59 -
Ruxolitinib Impurity 152
BACK ORDERRS-R005035 -
Ruxolitinib Impurity 153
BACK ORDERRS-I516286 -
Ruxolitinib Impurity 157
IN STOCKRS-I516275 -
Ruxolitinib Impurity 189
IN STOCKRS-R005033 -
Ruxolitinib Impurity 235
IN STOCKRS-R005039 -
Ruxolitinib Impurity 238
IN STOCKRS-R005002 -
Ruxolitinib Impurity 239
BACK ORDERRS-R005004 -
Ruxolitinib Impurity 240
CUSTOM SYNTHESISRS-R005005 -
Ruxolitinib Impurity 241
IN STOCKRS-R005007 -
Ruxolitinib Impurity 242
IN STOCKRS-R005009 -
Ruxolitinib Impurity 243
CUSTOM SYNTHESISRS-R005014 -
Ruxolitinib Impurity 244
IN STOCKRS-R005017 -
Ruxolitinib Impurity 245
IN STOCKRS-R005018 -
Ruxolitinib Impurity 247
IN STOCKRS-R005023 -
Ruxolitinib Impurity 248
IN STOCKRS-R005025 -
Ruxolitinib Impurity 249
IN STOCKRS-R005036 -
Ruxolitinib Impurity 250
IN STOCKRS-R005041 -
Ruxolitinib Impurity 284
IN STOCKRS-R005038
![Chemical structure of (2R)-N-[(1R)-1-(Hydroxydiphenylmethyl)-3-methylbutyl]-2-pyrrolidinecarboxamide](/structures/w4/PWBULUUPVDXEQS-NHCUHLMSSA-N.webp?v=8)
![Chemical structure of (4-Chloro-7H-pyrrolo[2,3-d]pyrimidin-7-yl)methyl Pivalate](/structures/w4/DTPDTZKIIYSQPO-UHFFFAOYSA-N.webp?v=8)
![Chemical structure of (betaR)-beta-Cyclopentyl-4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazole-1-propanenitrile sulfate](/structures/w4/LGJWVXWQCTZSGC-XFULWGLBSA-N.webp?v=8)
![Chemical structure of (Z)-3-hydroxy-2-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)acrylaldehyde](/structures/w4/XXYZFTPCGKZYTN-ZZXKWVIFSA-N.webp?v=8)
![Chemical structure of 4-Methyl-7H-pyrrolo[2,3-d]pyrimidine](/structures/w4/QWIAHMVNMONKCU-UHFFFAOYSA-N.webp?v=8)
![Chemical structure of 7H-Pyrrolo[2,3-d]pyrimidin-4-ol](/structures/w4/FBMZEITWVNHWJW-UHFFFAOYSA-N.webp?v=8)
![Chemical structure of Benzyl 4-methyl-7H-pyrrolo[2,3-d]pyrimidine-7-carboxylate](/structures/w4/YFYUXRYRUKBCBR-UHFFFAOYSA-N.webp?v=8)
Pharmacopoeial names (EP, USP, BP, JP) are used for identification purposes only and do not imply endorsement by those bodies. This product is supplied for laboratory and research use only — not for human or veterinary use.